Originally published byEU-Startups
Vienna-based Epitome Therapeutics, a BioTech company advancing precision epigenome editing for programmable gene expression, today announced a total funding of €4 million to advance development programmes and grow the company’s team. The pre-seed round, comprising an oversubscribed €2 million pre-seed round and €2 million in non-dilutive grant funding, was co-led by XISTA Science Ventures and […]
The post Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Leiden-based Whispp raises €5M to scale on-device voice reconstruction AI technology globally
3h ago
IBM teases new rackable mainframes that ‘complete’ the z17 family
7h ago
Boffins bet on quantum computers, AI supers to solve fusion fuel dilemma
13h ago
Software engineers can still rake in big bucks by working for fast-growing companies
13h ago
Madlad builds homebrew GPU using 8,192 RISC-V chips
13h ago